Nouvelle déclaration d'incident
No de la demande: 2008-4180
Numéro de référence du titulaire d'homologation: Prosar case 1-16402903
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: VIRGINIA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-125
Nom du produit: UltraGuard Flea and Tick Spray for Dogs 16 fl oz
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Autre
Dog / Chien
Pomeranian
1
Femme
4.5
12.5
lbs
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Oui
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-16402903: The reporter called on 7/15/08 to report the illness of her parent¿s female dog after the application of a topical flea and tick product containing the active ingredient Tetrachlorvinphos (organophosphate). According to the reporter, the product had been applied about 1 week prior to the call. On 7/12, the dog had developed lethargy, anorexia, and diarrhea. She had been taken to a veterinarian on 7/14, where blood had been drawn and the dog has been discharged. As of the time of the call, the dog had been taken back to the veterinarian based on the results of the lab work. Atropine treatment had been started but per the reporter, the dog had developed dyspnea, lacrimation, salivation, miosis, micturition, muscle tremors, muscle weakness, ataxia, agitation, paralysis, and had slipped into a coma. The active ingredient was discussed with the reporter, as was a cholinesterase test. A recommendation was made regarding treatment for organophosphate exposure (Atropine and 2-PAM). A follow-up call on 7/17 revealed that the dog had passed away the evening of 7/15. The reporter stated that a cholinesterase test had been done and that the attending veterinarian would be calling when he had received the results. The attending veterinarian called on 7/25/08 to report the results of the cholinesterase testing. According to the veterinarian, the dog had presented on 7/14 for vomiting. By the next day, she had developed miosis, salivation, lacrimation, and diarrhea. Aggressive therapy had been initiated with IV fluids and atropine every few hours to try and reverse a presumed organophosphate toxicity. The dog had passed away about 9 p.m. on 7/15. The cholinesterase test had come back low at 827 (normal 1271-5101).
Mort